Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1a

Quinoline-based molecules are major constituents in natural products, active pharmacophores, and have excellent biological activities. Using 2H-thiopyrano[2,3-b]quinoline derivatives and CB1a protein (PDB ID: 2IGR), the molecular docking study has been revealed in this article. The study of in silic...

Full description

Bibliographic Details
Main Authors: Shivangi Sharma, Shivendra Singh
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Interdisciplinary Perspectives on Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2023/1618082
_version_ 1797945513367044096
author Shivangi Sharma
Shivendra Singh
author_facet Shivangi Sharma
Shivendra Singh
author_sort Shivangi Sharma
collection DOAJ
description Quinoline-based molecules are major constituents in natural products, active pharmacophores, and have excellent biological activities. Using 2H-thiopyrano[2,3-b]quinoline derivatives and CB1a protein (PDB ID: 2IGR), the molecular docking study has been revealed in this article. The study of in silico molecular docking analysis of such derivatives to determine the binding affinity, residual interaction, and hydrogen bonding of several 2H-thiopyrano[2,3-b]quinolines against CB1a is reported here. The current work demonstrated that 2H-thiopyrano[2,3-b]quinoline derivatives could be effective antitumor agents to produce potent anticancer medicines in the near future.
first_indexed 2024-04-10T20:56:18Z
format Article
id doaj.art-128276f7e6d34e649614e4e8078edde5
institution Directory Open Access Journal
issn 1687-7098
language English
last_indexed 2024-04-10T20:56:18Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Interdisciplinary Perspectives on Infectious Diseases
spelling doaj.art-128276f7e6d34e649614e4e8078edde52023-01-23T00:56:19ZengHindawi LimitedInterdisciplinary Perspectives on Infectious Diseases1687-70982023-01-01202310.1155/2023/1618082Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1aShivangi Sharma0Shivendra Singh1Department of Applied ChemistryDepartment of Applied ChemistryQuinoline-based molecules are major constituents in natural products, active pharmacophores, and have excellent biological activities. Using 2H-thiopyrano[2,3-b]quinoline derivatives and CB1a protein (PDB ID: 2IGR), the molecular docking study has been revealed in this article. The study of in silico molecular docking analysis of such derivatives to determine the binding affinity, residual interaction, and hydrogen bonding of several 2H-thiopyrano[2,3-b]quinolines against CB1a is reported here. The current work demonstrated that 2H-thiopyrano[2,3-b]quinoline derivatives could be effective antitumor agents to produce potent anticancer medicines in the near future.http://dx.doi.org/10.1155/2023/1618082
spellingShingle Shivangi Sharma
Shivendra Singh
Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1a
Interdisciplinary Perspectives on Infectious Diseases
title Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1a
title_full Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1a
title_fullStr Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1a
title_full_unstemmed Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1a
title_short Molecular Docking Study for Binding Affinity of 2H-thiopyrano[2,3-b]quinoline Derivatives against CB1a
title_sort molecular docking study for binding affinity of 2h thiopyrano 2 3 b quinoline derivatives against cb1a
url http://dx.doi.org/10.1155/2023/1618082
work_keys_str_mv AT shivangisharma moleculardockingstudyforbindingaffinityof2hthiopyrano23bquinolinederivativesagainstcb1a
AT shivendrasingh moleculardockingstudyforbindingaffinityof2hthiopyrano23bquinolinederivativesagainstcb1a